• About
  • Subscribe
  • Advertise
  • Contact
Saturday, March 14, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

Rayner’s EMV lens wins prestigious King’s Award for Enterprise 2025

by Staff Writer
May 9, 2025
in Cataract, Company updates & acquisitions, Extended depth of focus (EDOF), Eye disease, International, Intraocular lenses (IOLs), Local, News, Ophthalmic equipment & diagnostics, Ophthalmic insights, Ophthalmic Treatments, Ophthalmology, Products, Toric IOLs
Reading Time: 2 mins read
A A
A Belgian firm has taken a big stake in Rayner. Image: Rayner.

A Belgian firm has taken a big stake in Rayner. Image: Rayner.

Share on FacebookShare on Twitter

Rayner, a manufacturer of intraocular lenses (IOLs), has announced that it has been honoured with the prestigious King’s Award for Enterprise 2025 for its innovative RayOne EMV increased range of focus IOL, which was developed in partnership with well-known Australian ophthalmologist, Professor Graham Barrett.

The company said that RayOne EMV, launched in 2020, uniquely extends a patient’s range of vision with a patented non-diffractive optic profile that utilises controlled positive spherical aberration.

That provides:

  • Up to 1.5 D increased range of focus with an emmetropic target.
  • Monofocal levels of contrast sensitivity, dysphotopsia and high levels of patient satisfaction.
  • A smoother transition between distance and near eyes with used in an Enhanced Monovision set-up.

Rayner said more than 400,000 RayOne EMV platform IOLs had now been shipped to more than 65 countries around the world, including Australia.

It said further expansion was planned with the recent approval of RayOne EMV by the Chinese NMPA, and the expected launch of RayOne EMV Toric in the US later this year.

RayOne EMV was honoured with The King’s Award for Enterprise 2025 in the Innovation category, in recognition of the impact the unique lens design has on the quality of patients’ lives.

Professor Graham Barrett played a key role in developing the RayOne EMV IOL.
Image: Graham Barrett.

On winning the award, Prof Barrett said: “RayOne EMV was the culmination of years of work so I am truly honoured to see this innovation recognised with  The King’s Award for Enterprise. I look forward to many more patients benefiting from RayOne EMV’s unique optical technology over the coming years.

“Surgeons and patients place immense trust in us to deliver life-enhancing visual outcomes, and this award is a powerful recognition of that,” said Mr Tim Clover, Rayner CEO.

“It reflects the real-world impact of our technology, the trust placed in RayOne EMV, and the commitment of our teams. After receiving the Queen’s Award for Enterprise for our RayOne injector in 2020, I am immensely proud to see Rayner once again acknowledged as a leader in cataract innovation.”

The award programme, now in its 59th year, is the most prestigious business award in the UK.

More reading 

Rayner’s world-first Galaxy spiral IOL – do believe the hype

Rayner introduces new and improved RayTrace

Rayner RayOne Galaxy ‘world’s first spiral IOL’

Related Posts

Virtual reality offers some possible risks but also a number of opportunities, particularly in eyecare. Image: Olly/stock.adobe.com.

Virtually real, visually relevant: What VR means for paediatric optometry

by Hayley McDonald
March 13, 2026

At the completion of this article, the reader should… •  Recognise common concerns and current evidence regarding the visual risks...

The Humphrey Field Analyzer has evolved over more than 40 years. Image: ZEISS.

ZEISS celebrating over 40 years of Humphrey Field Analyzer

by Rob Mitchell
March 13, 2026

ZEISS is celebrating over 40 years of the Humphrey Field Analyzer with promotional discounts on selected HFA 3 models for...

David Beckham's new range includes sunglasses and optical frames across two product lines. Image: Safilo

Safilo launches David Beckham spring/summer range

by Staff Writer
March 13, 2026

Safilo Group has announced the release of the spring/summer 2026 collection from Eyewear by David Beckham. The company says the...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited